ArticleHeart rhythm O22026

A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design.

Oussama M Wazni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.